Last reviewed · How we verify

NCT04288960

Validity of a Belt Mounted Accelerometer to Assess Walking Measures in Patients With Chronic Stroke

Suspended Last updated 26 May 2022
What this trial tests

trial testing Gwalk accelerometer walking trials in Stroke in 20 participants. Suspended.

Timeline
1 September 2022
Primary endpoint
30 December 2022
30 December 2022

Quick facts

Lead sponsorUniversity of Winchester
StatusSuspended
Study typeOBSERVATIONAL
Enrollment20
Start date1 September 2022
Primary completion30 December 2022
Estimated completion30 December 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Winchester

Who can join

Eligibility, any sex, with Stroke or Gait, Hemiplegic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to validate the G-walk for several gait parameters, tested against a gold standard three dimensional camera system. This research will inform researchers and practitioners as to whether the G-Walk is a suitable and valid tool to easily assess walking ability in people with chronic stroke.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other University of Winchester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04288960.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing